J&J ULTRAM PAIN RELIEVER LAUNCH TO PHYSICIANS SET FOR MID-APRIL; COMPANY COMMITS TO PHASE IV STUDIES AND SURVEILLANCE TO DETECT ABUSE POTENTIAL
Executive Summary
Johnson & Johnson's professional launch of the prescription analgesic Ultram (tramadol) will highlight the drug's "unique dual mechanism of action," the firm said March 7.